New guidance on the use of medicinal cannabis for chronic non-cancer pain in veterans
#72 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
This guidance provides clinicians with evidence-based recommendations for cannabis use in chronic non-cancer pain management, addressing a common condition where veterans often have limited treatment options and high opioid use. Veterans with chronic pain can now access a standardized clinical framework that helps providers weigh cannabis as part of a comprehensive pain management strategy while understanding its efficacy and safety profile. The guidance reduces prescribing uncertainty and helps clinicians have informed conversations with patients about cannabis as an alternative or adjunctive therapy when conventional treatments are inadequate or poorly tolerated.
New clinical guidance has been released to support healthcare providers in prescribing medicinal cannabis for chronic non-cancer pain management in veterans, a population with high rates of pain-related conditions and opioid use disorder. The guidance synthesizes current evidence regarding efficacy, safety, and appropriate patient selection for cannabis-based treatments in this specific population, addressing gaps that previously existed in evidence-based recommendations for this indication. For veteran-treating clinicians, this guidance provides a structured framework for evaluating cannabis as an adjunctive or alternative pain management strategy, particularly relevant given the urgency to reduce opioid prescribing while maintaining effective analgesia. The recommendations clarify which patient phenotypes may benefit most from cannabis therapy, dosing considerations, and monitoring parameters to optimize outcomes and mitigate adverse effects. Veterans with chronic non-cancer pain who have failed conventional therapies or have contraindications to opioids represent a potential population for whom cannabis may offer therapeutic benefit under appropriate clinical supervision. Clinicians should review this guidance to establish evidence-informed protocols for cannabis counseling, titration, and follow-up in their veteran patient populations.
“We’re seeing a growing body of peer-reviewed evidence that cannabis can provide meaningful relief for some veterans with chronic pain who haven’t responded to conventional options, but I’m careful to emphasize that this remains an individualized decision requiring thorough screening for contraindications and realistic conversations about what the data actually shows versus patient expectations.”
💊 While emerging evidence suggests medicinal cannabis may offer some benefit for certain veterans with chronic non-cancer pain who have exhausted conventional options, clinicians should recognize that the evidence base remains modest and heterogeneous, with most studies examining short-term outcomes and limited head-to-head comparisons with established analgesics. This guidance is particularly relevant for the veteran population, who experience high rates of chronic pain and may have limited tolerance for opioids due to concurrent substance use disorders or prior exposure, yet providers must carefully assess individual risk factors including cannabis use disorder history, cognitive impairment, fall risk, and potential drug interactions before initiating therapy. The practical challenge lies in the tension between offering a potentially useful alternative for truly refractory pain cases and avoiding cannabis as a first-line substitute for multimodal pain management that includes physical therapy, psychological interventions, and judicious use of conventional medications. Clinicians should use this guidance to inform shared decision-
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: